Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

471 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Colchicine in Patients with Chronic Coronary Disease.
Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, The SHK, Xu XF, Ireland MA, Lenderink T, Latchem D, Hoogslag P, Jerzewski A, Nierop P, Whelan A, Hendriks R, Swart H, Schaap J, Kuijper AFM, van Hessen MWJ, Saklani P, Tan I, Thompson AG, Morton A, Judkins C, Bax WA, Dirksen M, Alings M, Hankey GJ, Budgeon CA, Tijssen JGP, Cornel JH, Thompson PL; LoDoCo2 Trial Investigators. Nidorf SM, et al. Among authors: tijssen jgp. N Engl J Med. 2020 Nov 5;383(19):1838-1847. doi: 10.1056/NEJMoa2021372. Epub 2020 Aug 31. N Engl J Med. 2020. PMID: 32865380 Clinical Trial.
Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias.
Hirsch A, Windhausen F, Tijssen JG, Oude Ophuis AJ, van der Giessen WJ, van der Zee PM, Cornel JH, Verheugt FW, de Winter RJ; Invasive versus Conservative Treatment in Unstable coronary Syndromes Investigators. Hirsch A, et al. Eur Heart J. 2009 Mar;30(6):645-54. doi: 10.1093/eurheartj/ehn438. Epub 2008 Sep 29. Eur Heart J. 2009. PMID: 18824461 Clinical Trial.
Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study.
Dirksen MT, Vink MA, Suttorp MJ, Tijssen JG, Patterson MS, Slagboom T, Kiemeneij F, Laarman GJ; Paclitaxel-Eluting Stent versus Conventional Stent; in Myocardial Infarction with ST-Segment Elevation (PASSION) investigators. Dirksen MT, et al. EuroIntervention. 2008 May;4(1):64-70. doi: 10.4244/eijv4i1a12. EuroIntervention. 2008. PMID: 19112781 Clinical Trial.
Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T.
Windhausen F, Hirsch A, Fischer J, van der Zee PM, Sanders GT, van Straalen JP, Cornel JH, Tijssen JG, Verheugt FW, de Winter RJ; Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) Investigators. Windhausen F, et al. Clin Chem. 2009 Jun;55(6):1118-25. doi: 10.1373/clinchem.2008.119669. Epub 2009 Apr 9. Clin Chem. 2009. PMID: 19359536 Clinical Trial.
Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention.
Claessen BE, van der Schaaf RJ, Verouden NJ, Stegenga NK, Engstrom AE, Sjauw KD, Kikkert WJ, Vis MM, Baan J Jr, Koch KT, de Winter RJ, Tijssen JG, Piek JJ, Henriques JP. Claessen BE, et al. JACC Cardiovasc Interv. 2009 Nov;2(11):1128-34. doi: 10.1016/j.jcin.2009.08.024. JACC Cardiovasc Interv. 2009. PMID: 19926056 Free article.
Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial.
Claessen BE, Beijk MA, Legrand V, Ruzyllo W, Manari A, Varenne O, Suttorp MJ, Tijssen JG, Miquel-Hebert K, Veldhof S, Henriques JP, Serruys PW, Piek JJ. Claessen BE, et al. Circ Cardiovasc Interv. 2009 Aug;2(4):339-47. doi: 10.1161/CIRCINTERVENTIONS.108.831800.108.831800. Epub 2009 Jul 22. Circ Cardiovasc Interv. 2009. PMID: 20031737 Free article. Clinical Trial.
Lenient versus strict rate control in patients with atrial fibrillation.
Van Gelder IC, Groenveld HF, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, Hillege HL, Bergsma-Kadijk JA, Cornel JH, Kamp O, Tukkie R, Bosker HA, Van Veldhuisen DJ, Van den Berg MP; RACE II Investigators. Van Gelder IC, et al. N Engl J Med. 2010 Apr 15;362(15):1363-73. doi: 10.1056/NEJMoa1001337. Epub 2010 Mar 15. N Engl J Med. 2010. PMID: 20231232 Free article. Clinical Trial.
Effect of multivessel coronary disease with or without concurrent chronic total occlusion on one-year mortality in patients treated with primary percutaneous coronary intervention for cardiogenic shock.
van der Schaaf RJ, Claessen BE, Vis MM, Hoebers LP, Koch KT, Baan J Jr, Meuwissen M, Engstrom AE, Kikkert WJ, Tijssen JG, de Winter RJ, Piek JJ, Henriques JP. van der Schaaf RJ, et al. Am J Cardiol. 2010 Apr 1;105(7):955-9. doi: 10.1016/j.amjcard.2009.11.014. Epub 2010 Feb 13. Am J Cardiol. 2010. PMID: 20346312
Histopathology of aspirated thrombus and its association with ST-segment recovery in patients undergoing primary percutaneous coronary intervention with routine thrombus aspiration.
Verouden NJ, Kramer MC, Li X, Meuwissen M, Koch KT, Henriques JP, Baan J, Vis MM, Piek JJ, van der Wal AC, Tijssen JG, de Winter RJ. Verouden NJ, et al. Catheter Cardiovasc Interv. 2011 Jan 1;77(1):35-42. doi: 10.1002/ccd.22616. Catheter Cardiovasc Interv. 2011. PMID: 20506526
471 results